Page 2 - Diagnostics Pillar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The partnership will optimise and scale the capacity needed to identify SARS-CoV-2 VOC and VOI

A new agreement reached by the Global Fund and several producers of COVID-19 antigen rapid diagnostic tests (Ag RDTs) has resulted in a significant drop in the price of these tests, potentially making the products more affordable for many governments of low- and middle-income countries.

The accuracy of existing molecular (PCR, NAAT) tests appears uncompromised by COVID-19 variant Omicron (B.1.1.529), designated a Variant of Concern by the World Health Organization (WHO) on Friday. Preliminary evidence suggests that this is also true for the accuracy of rapid antigen tests.

21 May 2021 ROME – G20 leaders and heads of international and regional organizations reaffirmed their commitment to fight pandemics and support the Access to COVID-19 Tools (ACT) Accelerator –a ground breaking collaboration of global partners to accelerate the development, production and equitable delivery of new tests, treatments, vaccines and health supplies worldwide. Meeting in Rome in the midst of the COVID-19 pandemic, leaders stressed the urgent need to increase investments in health and build inclusive and resilient health systems to prepare the world against pandemics and respond...

G20 leaders boost support of the Access to COVID-19 Tools (ACT) Accelerator but urgent and immediate action is needed to maintain momentum Format 21 May 2021 | Geneva -- World leaders today met at the Global Health Summit, co-hosted by the European Commission and Italy as part of its G20 presidency, to adopt an agenda to overcome the COVID-19 pandemic, and develop and endorse a Rome Declaration of principles, at a time when the virus is surging and spreading uncontrollably in many parts of the world. With nine people losing their lives to COVID-19 every minute, and as the risk of even more tr...